<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1654">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05139628</url>
  </required_header>
  <id_info>
    <org_study_id>PVC related BSIs</org_study_id>
    <nct_id>NCT05139628</nct_id>
  </id_info>
  <brief_title>Peripheral Venous Catheter Related Blood Stream Infections</brief_title>
  <official_title>The Impact of Skin Colonization at the Peripheral Venous Catheter Insertion Sites on Catheter Tip Colonization and Catheter Related Blood Stream Infections Among Pediatric Oncology Patients.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this work is to:&#xD;
&#xD;
        1. Study the impact of PIVC skin colonization on catheter tip colonization and the&#xD;
           development of CRBSI&#xD;
&#xD;
        2. isolate and identify the organisms causing peripheral venous catheter related blood&#xD;
           stream infections in pediatric oncology patients.&#xD;
&#xD;
        3. perform antimicrobial sensitivity testing of isolated organisms.&#xD;
&#xD;
        4. identify the associated risk factors that lead to CRBSIs in such group of patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Peripheral intravenous catheters (PIVCs) are small flexible tubes that are vital for the&#xD;
      delivery of therapies, such as fluids, drugs, and blood transfusions that are required in up&#xD;
      to 70% of hospitalized patients. The PIVC is introduced through the skin into the peripheral&#xD;
      veins of the arms, hands, or lower limbs. Despite their relatively short-term use (typically&#xD;
      &lt;1 week) they are a potential source of catheter-related bloodstream infections (CRBSIs)&#xD;
      implicated in up to 5% of nosocomial bacteremias, with a prevalence of 0.67%-2.4 %. Such&#xD;
      infections increase a patient's risk of death, discomfort, and length of hospital stay.&#xD;
&#xD;
      Among pediatric patients with hemato-oncologic disease, intravascular catheter-associated&#xD;
      bloodstream infection is the most common cause of bloodstream infections leading to increased&#xD;
      mortality and morbidity in such patients. The Mortality rates of bloodstream infections in&#xD;
      patients with malignancy are significantly higher than in patients without malignancy. There&#xD;
      is a paucity of data on blood stream infections (BSIs) generally amongst paediatric oncology&#xD;
      patients in low and middle-income countries, and especially CRBSIs.&#xD;
&#xD;
      Cancer patients are predisposed to BSI for several reasons:&#xD;
&#xD;
        -  Alterations in anatomic barriers, both internal and external leading to enhance access&#xD;
           of bacteria and fungi to the bloodstream.&#xD;
&#xD;
        -  Changes in both cell-mediated and humoral immunity occur related both to the primary&#xD;
           tumor and the subsequent treatment.&#xD;
&#xD;
        -  Infectious complications in pediatric hematology-oncology patients have been&#xD;
           significantly associated with the presence of indwelling catheters.&#xD;
&#xD;
      With most clinical studies focusing on central vascular catheters, infections associated with&#xD;
      short peripheral venous catheters have received little attention. While central&#xD;
      line-associated bloodstream infections have become an important metric in assessing patient&#xD;
      safety, peripheral intravenous catheters (PVCs) remain underappreciated as an intravascular&#xD;
      device that is also responsible for catheter-associated bloodstream infections.&#xD;
&#xD;
      Catheter related bloodstream infection (CRBSI) is defined as the presence of bacteremia&#xD;
      originating from an intravenous catheter. An estimated 60% of these CRBSIs are associated&#xD;
      with the patient's skin flora.The skin is a complex environment that provides greater space&#xD;
      for diverse commensal and pathogenic microbes. Catheter colonization occurs by progression of&#xD;
      microorganisms to the tip of the catheter along either the inner surface (≥7 days of&#xD;
      indwelling time) or the outer surface (&lt;7 days of indwelling time) of the catheter. Even&#xD;
      despite skin site decontamination with antiseptic prior to PIVC insertion, bacteria may&#xD;
      remain in the hair follicles and lower dermis, and immediately after post insertion catheter,&#xD;
      the bacteria begin proliferation. If conditions are particularly favorable, for example&#xD;
      moisture from diaphoresis, blood ooze, and numerous hair follicles, bacterial growth becomes&#xD;
      faster. Skin bacteria can progressively colonize down the insertion site along the PIVC&#xD;
      tract. However, the impact of PIVC skin site colonization on tip colonization and the&#xD;
      development of CRBSI has never been investigated comprehensively.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 1, 2021</start_date>
  <completion_date type="Anticipated">January 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Study the impact of Peripheral intravenous catheter skin colonization on catheter tip colonization and the development of Catheter related blood stream infections in pediatric oncology patients and Identify the associated risk factors.</measure>
    <time_frame>1 year (Anticipated)</time_frame>
    <description>Isolate and identify the organisms causing CRBSIs and perform antimicrobial sensitivity testing of the isolated organisms.</description>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Catheter-Related Infections</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>microbiological identification of samples (skin and blood samples)</intervention_name>
    <description>Samples will be plated on blood culture plates and will be confirmed biochemically.&#xD;
Complete Bacteriological diagnosis will be done. The TTP of each BC bottle will be recorded</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        • This study will be conducted on pediatric patients admitted to South Egypt Cancer&#xD;
        Institute -Assiut University with more than 48hrs of catheter insertion.Patients ( age &gt; 40&#xD;
        days up to 18 years) from both sexes.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The following data will be collected for each patient :&#xD;
&#xD;
          -  Age&#xD;
&#xD;
          -  Sex&#xD;
&#xD;
          -  Type of malignancy&#xD;
&#xD;
          -  PIVC location&#xD;
&#xD;
          -  Antimicrobial use&#xD;
&#xD;
          -  Parenteral nutrition&#xD;
&#xD;
          -  Dwell-time&#xD;
&#xD;
          -  The reason for removal (eg, treatment complete, PIVC complications, or suspected&#xD;
             infection, or routinely (72-96 hours).&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Patient with existing bloodstream infections.&#xD;
&#xD;
          -  or those with any type of infections&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Days</minimum_age>
    <maximum_age>18 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Nahla M Elsherbiny, Prof. Dr.</last_name>
    <role>Study Director</role>
    <affiliation>Professor of Medical Microbiology and Immunology Faculty of Medicine - Assiut University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mona H Abdel-Rahim, A. prof.</last_name>
    <role>Study Director</role>
    <affiliation>Assistant professor of Medical Microbiology and Immunology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mariam M AbdelHafeez, MBBS</last_name>
    <phone>+201100862681</phone>
    <email>dr_mariam_h@yahoo.com</email>
  </overall_contact>
  <reference>
    <citation>El-Mahallawy H, Sidhom I, El-Din NH, Zamzam M, El-Lamie MM. Clinical and microbiologic determinants of serious bloodstream infections in Egyptian pediatric cancer patients: a one-year study. Int J Infect Dis. 2005 Jan;9(1):43-51.</citation>
    <PMID>15603994</PMID>
  </reference>
  <reference>
    <citation>Gaur A, Giannini MA, Flynn PM, Boudreaux JW, Mestemacher MA, Shenep JL, Hayden RT. Optimizing blood culture practices in pediatric immunocompromised patients: evaluation of media types and blood culture volume. Pediatr Infect Dis J. 2003 Jun;22(6):545-52.</citation>
    <PMID>12799512</PMID>
  </reference>
  <reference>
    <citation>Grice EA, Segre JA. The skin microbiome. Nat Rev Microbiol. 2011 Apr;9(4):244-53. doi: 10.1038/nrmicro2537. Review. Erratum in: Nat Rev Microbiol. 2011 Aug;9(8):626.</citation>
    <PMID>21407241</PMID>
  </reference>
  <reference>
    <citation>Hughes WT, Armstrong D, Bodey GP, Brown AE, Edwards JE, Feld R, Pizzo P, Rolston KV, Shenep JL, Young LS. 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America. Clin Infect Dis. 1997 Sep;25(3):551-73. Review.</citation>
    <PMID>9314442</PMID>
  </reference>
  <reference>
    <citation>Kong HH. Skin microbiome: genomics-based insights into the diversity and role of skin microbes. Trends Mol Med. 2011 Jun;17(6):320-8. doi: 10.1016/j.molmed.2011.01.013. Epub 2011 Mar 4. Review.</citation>
    <PMID>21376666</PMID>
  </reference>
  <reference>
    <citation>Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med. 1977 Jun 9;296(23):1305-9.</citation>
    <PMID>323710</PMID>
  </reference>
  <reference>
    <citation>Nørgaard M, Larsson H, Pedersen G, Schønheyder HC, Sørensen HT. Haematological malignancies--a predictor of a poor outcome in patients with bacteraemia. J Infect. 2006 Sep;53(3):190-8. Epub 2005 Dec 13.</citation>
    <PMID>16352338</PMID>
  </reference>
  <reference>
    <citation>Rickard CM, Marsh N, Webster J, Runnegar N, Larsen E, McGrail MR, Fullerton F, Bettington E, Whitty JA, Choudhury MA, Tuffaha H, Corley A, McMillan DJ, Fraser JF, Marshall AP, Playford EG. Dressings and securements for the prevention of peripheral intravenous catheter failure in adults (SAVE): a pragmatic, randomised controlled, superiority trial. Lancet. 2018 Aug 4;392(10145):419-430. doi: 10.1016/S0140-6736(18)31380-1. Epub 2018 Jul 26.</citation>
    <PMID>30057103</PMID>
  </reference>
  <reference>
    <citation>Safdar N, Maki DG. The pathogenesis of catheter-related bloodstream infection with noncuffed short-term central venous catheters. Intensive Care Med. 2004 Jan;30(1):62-7. Epub 2003 Nov 26.</citation>
    <PMID>14647886</PMID>
  </reference>
  <reference>
    <citation>Sato A, Nakamura I, Fujita H, Tsukimori A, Kobayashi T, Fukushima S, Fujii T, Matsumoto T. Peripheral venous catheter-related bloodstream infection is associated with severe complications and potential death: a retrospective observational study. BMC Infect Dis. 2017 Jun 17;17(1):434. doi: 10.1186/s12879-017-2536-0.</citation>
    <PMID>28623882</PMID>
  </reference>
  <reference>
    <citation>Soifer NE, Borzak S, Edlin BR, Weinstein RA. Prevention of peripheral venous catheter complications with an intravenous therapy team: a randomized controlled trial. Arch Intern Med. 1998 Mar 9;158(5):473-7.</citation>
    <PMID>9508225</PMID>
  </reference>
  <reference>
    <citation>Webster J, Osborne S, Rickard CM, Marsh N. Clinically-indicated replacement versus routine replacement of peripheral venous catheters. Cochrane Database Syst Rev. 2019 Jan 23;1:CD007798. doi: 10.1002/14651858.CD007798.pub5.</citation>
    <PMID>30671926</PMID>
  </reference>
  <reference>
    <citation>Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis. 2003 May 1;36(9):1103-10. Epub 2003 Apr 14.</citation>
    <PMID>12715303</PMID>
  </reference>
  <verification_date>December 2021</verification_date>
  <study_first_submitted>November 18, 2021</study_first_submitted>
  <study_first_submitted_qc>November 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 1, 2021</study_first_posted>
  <last_update_submitted>December 6, 2021</last_update_submitted>
  <last_update_submitted_qc>December 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Mariam Mohamed Abdel-Hafeez</investigator_full_name>
    <investigator_title>Assistant Lecturer</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Catheter-Related Infections</mesh_term>
    <mesh_term>Sepsis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

